LGI3 (Leucine Rich Repeat LGI Family Member 3)

A secreted protein involved in neuronal development and synaptic function, linked to epilepsy and cancer.

Gene Information Card

Symbol LGI3
Full Name Leucine Rich Repeat LGI Family Member 3
Gene Type Protein coding
Chromosomal Location 8p21.3
NCBI Gene ID 203190 ncbi.nlm.nih.gov/gene/203190
Ensembl ID ENSG00000168484
UniProt ID Q8N9I0
OMIM ID 609562
HGNC ID 18712
Aliases LGIL3, LGI3a, LGI3b

Description

LGI3 (Leucine Rich Repeat LGI Family Member 3) encodes a secreted protein belonging to the leucine-rich repeat (LRR) superfamily. The protein is predominantly expressed in the brain and plays a role in neuronal development, synaptic transmission, and myelination. LGI3 interacts with ADAM22 and ADAM23 to regulate voltage-gated potassium channels. Mutations and altered expression of LGI3 have been implicated in epilepsy, glioma, and other cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Epilepsy (familial temporal lobe epilepsy) LGI3 mutations may disrupt synaptic protein complexes, impairing potassium channel function and increasing neuronal excitability. ClinVar, OMIM
Glioma LGI3 expression is downregulated in gliomas; loss of LGI3 promotes tumor cell migration and invasion via altered ADAM22/23 signaling. COSMIC, NCBI PubMed
Lung cancer LGI3 hypermethylation and reduced expression correlate with poor prognosis; LGI3 may act as a tumor suppressor. COSMIC, NCBI PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Brain (cerebral cortex) 12.5 High
Brain (cerebellum) 10.8 High
Testis 3.2 Medium
Lung 1.5 Low
Liver 0.3 Not detected
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 8.7 Neuronal model
U87MG (glioma) 2.1 Reduced expression
A549 (lung carcinoma) 1.0 Low expression
HEK293 (embryonic kidney) 0.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.101C>T (p.Thr34Met) Missense <0.01% Potential loss of function; reported in epilepsy
c.457G>A (p.Gly153Arg) Missense <0.01% Unknown significance; observed in glioma
c.1234delC (p.Leu412Trpfs*5) Frameshift <0.01% Loss of function; truncation
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations (e.g., c.1234delC) lead to truncated protein, impairing secretion and ADAM22 binding.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in LGI3.

Dominant Negative (DN)

Missense mutations (e.g., p.Thr34Met) may interfere with wild-type LGI3 function in heterozygous state, but evidence is limited.

Pathways

• ADAM22/23 signaling pathway
• Voltage-gated potassium channel complex assembly
• Synaptic adhesion and transmission

Protein Summary

LGI3 is a 557-amino acid secreted protein containing an N-terminal signal peptide, four leucine-rich repeats (LRRs), and a C-terminal EPTP (epilepsy-associated repeat) domain. It is synthesized as a preproprotein and cleaved to release the mature protein. LGI3 binds to ADAM22 and ADAM23 on the cell surface, facilitating the clustering of voltage-gated potassium channels (Kv1.1) at synapses. The protein is critical for neuronal excitability regulation, myelination, and tumor suppression. In cancer, LGI3 loss promotes epithelial-mesenchymal transition and metastasis.

Related Products

Product name Cat.No. Species Gene ID
LGI3 Knockout HEK293 Cell Line EDJ-KQ5453 Human 203190 Details Get a Quote
LGI3 Knockout A-549 Cell Line EDJ-KQ28642 Human 203190 Details Get a Quote
LGI3 Knockout HCT 116 Cell Line EDJ-KQ28643 Human 203190 Details Get a Quote
LGI3 Knockout HeLa Cell Line EDJ-KQ59042 Human 203190 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: